157 related articles for article (PubMed ID: 8109924)
1. In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor.
Otto MJ; Reid CD; Garber S; Lam PY; Scarnati H; Bacheler LT; Rayner MM; Winslow DL
Antimicrob Agents Chemother; 1993 Dec; 37(12):2606-11. PubMed ID: 8109924
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitor.
Winslow DL; Mayers D; Scarnati H; Lane J; Bincsik A; Otto MJ
AIDS; 1994 Jun; 8(6):753-6. PubMed ID: 8086132
[TBL] [Abstract][Full Text] [Related]
3. In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine.
Kageyama S; Mimoto T; Murakawa Y; Nomizu M; Ford H; Shirasaka T; Gulnik S; Erickson J; Takada K; Hayashi H
Antimicrob Agents Chemother; 1993 Apr; 37(4):810-7. PubMed ID: 8494379
[TBL] [Abstract][Full Text] [Related]
4. CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity.
Alteri E; Bold G; Cozens R; Faessler A; Klimkait T; Lang M; Lazdins J; Poncioni B; Roesel JL; Schneider P
Antimicrob Agents Chemother; 1993 Oct; 37(10):2087-92. PubMed ID: 8257128
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+.
Davis DA; Branca AA; Pallenberg AJ; Marschner TM; Patt LM; Chatlynne LG; Humphrey RW; Yarchoan R; Levine RL
Arch Biochem Biophys; 1995 Sep; 322(1):127-34. PubMed ID: 7574666
[TBL] [Abstract][Full Text] [Related]
6. Characterization and use of a recombinant retroviral system for the analysis of drug resistant HIV.
Medina DJ; Tung PP; Nelson CJ; Sathya B; Casareale D; Strair RK
J Virol Methods; 1998 Apr; 71(2):169-76. PubMed ID: 9626950
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of constant infusion of A-77003, an inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, in limiting acute HIV-1 infection in vitro.
Bilello JA; Bilello PA; Kort JJ; Dudley MN; Leonard J; Drusano GL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2523-7. PubMed ID: 8585738
[TBL] [Abstract][Full Text] [Related]
8. Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease.
Jacobsen H; Ahlborn-Laake L; Gugel R; Mous J
J Virol; 1992 Aug; 66(8):5087-91. PubMed ID: 1378515
[TBL] [Abstract][Full Text] [Related]
9. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
[TBL] [Abstract][Full Text] [Related]
10. Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
Lamarre D; Croteau G; Wardrop E; Bourgon L; Thibeault D; Clouette C; Vaillancourt M; Cohen E; Pargellis C; Yoakim C; Anderson PC
Antimicrob Agents Chemother; 1997 May; 41(5):965-71. PubMed ID: 9145853
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the retroviral HIV-proteinase impairs maturation to infectious human immunodeficiency virus (HIV).
Nitschko H; Schätzl H; Gelderblom HR; Oswald M; von der Helm K
Biomed Biochim Acta; 1991; 50(4-6):655-8. PubMed ID: 1801738
[TBL] [Abstract][Full Text] [Related]
12. Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures.
Winters MA; Holodniy M; Katzenstein DA; Merigan TC
PCR Methods Appl; 1992 May; 1(4):257-62. PubMed ID: 1477661
[TBL] [Abstract][Full Text] [Related]
13. Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.
Kucera LS; Iyer NP; Puckett SH; Buckheit RW; Westbrook L; Toyer BR; White EL; Germany-Decker JM; Shannon WM; Chen RC
AIDS Res Hum Retroviruses; 1993 Apr; 9(4):307-14. PubMed ID: 7685612
[TBL] [Abstract][Full Text] [Related]
14. A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro.
Kageyama S; Hoekzema DT; Murakawa Y; Kojima E; Shirasaka T; Kempf DJ; Norbeck DW; Erickson J; Mitsuya H
AIDS Res Hum Retroviruses; 1994 Jun; 10(6):735-43. PubMed ID: 8074936
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
Crowe SM; McGrath MS; Elbeik T; Kirihara J; Mills J
J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates.
Shafer RW; Kozal MJ; Katzenstein DA; Lipil WH; Johnstone IF; Merigan TC
J Virol Methods; 1993 Mar; 41(3):297-310. PubMed ID: 8097199
[TBL] [Abstract][Full Text] [Related]
17. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
[TBL] [Abstract][Full Text] [Related]
18. HIV proteinase inhibitors.
Roberts NA; Craig JC; Duncan IB
Biochem Soc Trans; 1992 May; 20(2):513-6. PubMed ID: 1397651
[No Abstract] [Full Text] [Related]
19. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.
Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF
Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133
[TBL] [Abstract][Full Text] [Related]
20. Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease.
Patick AK; Mo H; Markowitz M; Appelt K; Wu B; Musick L; Kalish V; Kaldor S; Reich S; Ho D; Webber S
Antimicrob Agents Chemother; 1996 Feb; 40(2):292-7. PubMed ID: 8834868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
